Form 4: Okta Director Robert Bernshteyn Granted 5,876 RSUs
Director Equity Grant
Okta, Inc. Director Robert Bernshteyn was granted 5,876 Restricted Stock Units, which will vest over three years starting December 2026.
Summary
- Robert Bernshteyn, a Director of Okta, Inc., was granted 5,876 Restricted Stock Units (RSUs).
- Each RSU represents the right to receive one share of Okta's Class A Common Stock.
- The grant date for this transaction was December 19, 2025.
- The RSUs will vest over a three-year period, with 33-1/3% vesting on December 19, 2026, and the remainder vesting in two equal annual installments thereafter.
- Vesting is contingent upon Mr. Bernshteyn's continued service with Okta.
Sentiment
Score: 6
Explanation: The grant of RSUs to a director is a neutral to slightly positive event, as it aligns interests and is a standard compensation practice. It doesn't indicate any immediate operational or financial performance changes, but rather a routine governance and compensation matter.
Positives
- The grant of Restricted Stock Units to a director aligns the director's interests with long-term shareholder value.
- The multi-year vesting schedule encourages continued service and commitment from the director.
Negatives
- Potential for minor dilution for existing shareholders when the RSUs eventually convert to common stock, though this is a standard practice for equity compensation.
Risks
- Dilution: The conversion of RSUs into Class A Common Stock will result in an increase in the number of outstanding shares, potentially diluting the ownership percentage of existing shareholders.
- Service Condition: The vesting of the RSUs is subject to the reporting person's continued service with the Issuer, meaning the shares may not fully vest if service is terminated.
Future Outlook
The vesting schedule for the granted Restricted Stock Units extends into future years, indicating a long-term incentive structure for the director, contingent on continued service.
Industry Context
Equity grants, particularly Restricted Stock Units with multi-year vesting schedules, are a common form of executive and director compensation in the technology industry. This practice is widely adopted to align the interests of leadership with the long-term performance and shareholder value creation of the company, especially in growth-oriented tech firms like Okta.
Stakeholder Impact
- Shareholders: Potential minor dilution upon vesting, but also increased alignment of director's interests with long-term share price performance.
- Employees: Standard equity compensation practices can positively influence employee morale and retention, though this specific grant is for a director.
Next Steps
- The first tranche of RSUs will vest on December 19, 2026.
- Subsequent tranches will vest in two equal annual installments thereafter.
Key Dates
| Date | Description |
|---|---|
| 12/19/2025 | Date of RSU grant transaction. |
| 12/22/2025 | Date the Form 4 was signed and filed. |
| 12/19/2026 | First vesting date for 33-1/3% of the granted RSUs. |
Recommendation
holdThis Form 4 filing reports a routine equity grant to a director as part of their compensation package. It does not contain information that would fundamentally alter the investment thesis for Okta, nor does it signal significant operational or financial changes. While it aligns the director's interests with long-term shareholder value, it is a standard event and does not warrant a change in investment recommendation based solely on this filing.
Keywords
Okta, OKTA, Robert Bernshteyn, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Form 4, Stock Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.